ClinicalTrials.gg
RecruitingNCT06745570STARUpdated Jul 20, 2026

Improving Sleep, Decision-Making, and Eating in Adolescents With Obesity

An interventional study of Lifestyle Modification and Sleep Intervention in Adolescent Overweight, Adolescent Obesity and Sleep, sponsored by Nemours Children's Clinic. Recruiting at 1 site in United States. Open to participants aged 14 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Nemours Children's Clinic · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Apr 2024, registered Dec 2024).
  • Started Apr 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
14 Years to 18 Years
Sex
All
01

Study summary

This study is being performed to understand the effects of a lifestyle modification and sleep intervention on weight loss outcomes in adolescence. The main question the study aims to answer is:

- What are the initial effects of a lifestyle modification and sleep intervention, including effects on weight, eating behaviors and dietary intake, and sleep?

Participants will:

  • Participate in remote, group-based, weekly weight loss and sleep coaching for 16 weeks.
  • Complete study assessments at baseline (pre-intervention), mid-intervention, and post-intervention.
  • Complete daily sleep diaries for three 7-day periods at each assessment point.
Read the detailed description

In this study, the investigators will develop, refine, and test a 16-session group-based lifestyle modification intervention for adolescents with overweight and obesity augmented with a sleep intervention. The investigators will develop the manual and pilot the intervention in an initial set of adolescents (n=10). The investigators will collect feedback from adolescents, parents, and clinicians, which will inform manual refinements. The investigators will complete an open trial (n=40) of the refined manual. For both phases, the investigators will recruit adolescents (ages 14-18) with overweight or obesity who endorse at least 1 type of sleep disturbance (i.e., too little, poor quality, poorly timed, or inconsistent sleep). Assessments of sleep, decision-making, problematic eating behaviors, energy intake, and weight will occur at baseline (week 0), mid-intervention (week 8) and post-intervention (week 16).

02

Conditions studied

  • Adolescent Overweight
  • Adolescent Obesity
  • Sleep
  • Eating Behaviors
  • Dietary Intake

Keywords

  • Adolescent Weight Loss
  • Adolescent Sleep
  • Adolescent Eating
03

In context

Pediatric Obesity

1,129 studies on the registry are indexed under Pediatric Obesity; 187 are open to participants now.

This study's planned enrollment of 50 is below the median of 100 across 870 interventional studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

Nemours Children's Clinic is the lead sponsor of 130 studies on the registry; 26 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ages 14-18
  • Fluent in English
  • percentile ≥ 85th percentile for sex-and-age
  • Has a parent or guardian who is willing and able to participate
  • Has at least one sleep disturbance. Eligible sleep disturbances are: a. Advanced sleep timing (sleep onset 11:00pm or later for 14-16 year-olds or 11:20pm or later for 17-18 year-olds at least 3 times per week), b. Difficulty falling asleep (taking ≥ 30 mins to get to sleep 3 or more nights per week), c. Short sleep (obtaining \< 7.5 hours of sleep per night 3 or more nights per week), and d. Sleep irregularity (having more than 2 hours of variability in sleep-wake schedule across one week

Exclusion criteria

Exclusion Criteria:

  • Experience of weight loss of ≥ 5% of body weight in the past 6 months
  • Current use of insomnia medication
  • Having recently begun or changed the dosage of any medication known to affect appetite or body composition within the last 3 months
  • Currently taking weight loss medications
  • Currently taking insulin
  • Diagnosed diabetes (type 1)
  • Any condition prohibiting physical activity
  • Diagnosis of an eating disorder
  • Diagnosis of obstructive sleep apnea
  • Recent or ongoing problem with drug abuse, alcohol abuse, or addiction
  • Currently pregnant or less than 3 months postpartum
  • Anticipation of a possible pregnancy in the next year
  • Unwillingness to report possible or confirmed pregnancies promptly during the course of the trial
  • Currently participating in treatment for eating or weight concerns
  • Does not have regular access to Wi-Fi connection to participate in study interventions.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Group Intervention

    All participants will receive group-based lifestyle modification and sleep treatment (16, 90-minute sessions over 16 weeks). All sessions will be delivered on Zoom (remotely) to small groups (n=5-10 each) of participants. The intervention involves lifestyle modification content (e.g., nutritional education, physical activity education, stimulus control, goal setting) and sleep content (e.g., psychoeducation regarding sleep and eating behavior, sleep tracking, establishing regular sleep-wake times).

    Behavioral: Lifestyle Modification and Sleep Intervention

Interventions

  • BehavioralLifestyle Modification and Sleep Intervention

    This study is being performed to develop, refine, and test the effects of a group lifestyle modification intervention augmented with a sleep intervention on weight loss, eating behaviors, and sleep outcomes. Results from this study will inform future studies to test the efficacy of this intervention. This intervention is being offered as part of a research study within Drexel University's WELL Center. Participants will receive remote, group-based, weekly weight loss and sleep coaching (90 minutes per coaching session) for 16 weeks.

06

What researchers measure

Primary outcomes

  1. Percent of 95th percentile BMI

    Height and weight will be measured at each assessment and used to calculate percent of 95th percentile BMI.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  2. Tri-ponderal mass index

    The investigators will also calculate tri-ponderal mass index (TMI; i.e., mass divided by height cubed) from measurements of height and weight.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  3. Body fat percentage

    Body fat percentage will also be derived from the Aria Air scale.

    Time frame: From enrollment to the end of the study (approximately 4 months)

Secondary outcomes

  1. Dietary intake

    Adolescent dietary intake will be assessed via 30-day dietary recalls using the VioScreen at the baseline and post-treatment assessments. This freely available and validated web-based tool enables automated, self-administered, 30-day recalls. The VioScreen provides item-level nutritional information as well as monthly totals of key nutrient variables. Mean intake of the following food/macronutrient groups will be calculated: fruits and vegetables, fat, saturated fat, protein, cholesterol, added sugars, and dietary fiber.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  2. Eating Disorder Examination

    The investigators will also assess adolescent eating behaviors using the Binge Module and the Compensatory Behaviors Module portions of the Eating Disorder Examination at each assessment point.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  3. Eating Disorder Examination Questionnaire

    The investigators will have adolescents and their parents complete the Eating Disorder Examination Questionnaire, a self-report measure of eating behaviors, and baseline and post-treatment.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  4. Average total sleep time

    Adolescent sleep diaries will be collected for a 1-week period prior to the initiation of the intervention, 1 week at mid-intervention and 1 week following the intervention. Average total sleep time will be calculated.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  5. Average bed time

    Adolescent sleep diaries will be collected for a 1-week period prior to the initiation of the intervention, 1 week at mid-intervention and 1 week following the intervention. Average bed time will be calculated.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  6. Average sleep latency

    Adolescent sleep diaries will be collected for a 1-week period prior to the initiation of the intervention, 1 week at mid-intervention and 1 week following the intervention. Average sleep latency will be calculated.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  7. Average weekday-weekend bed time shift

    Adolescent sleep diaries will be collected for a 1-week period prior to the initiation of the intervention, 1 week at mid-intervention and 1 week following the intervention. Average weekday-weekend bed time shift will be calculated.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  8. Pittsburgh Sleep Quality Index

    Adolescents and their parents will complete the Pittsburgh Sleep Quality Index, a well-validated overall measure of sleep quality, at each assessment point.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  9. Morningness Eveningness Questionnaire

    The investigators will use the Morningness Eveningness Questionnaire at each assessment point to assess differences in the degree to which adolescents are active and alert at certain times of the day.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  10. Insomnia Severity Index

    The investigators will have participants complete the Insomnia Severity Index to assess insomnia.

    Time frame: From enrollment to the end of the study (approximately 4 months)

  11. Sleep - Fitbit data

    Participants will wear a FitBit during the assessment weeks, which will gather accelerometry data on sleep.

    Time frame: From enrollment to the end of the study (approximately 4 months)

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Jan 2027, 32 months after the start.

Of 539 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 32 months is above that.

Counting every sponsor, half of 541 studies reached it within 25 months; a quarter within 11 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2024
First posted
Dec 20, 2024
StartActual
Apr 18, 2024
Primary completionEst.
Jan 15, 2027
CompletionEst.
Jan 31, 2027
Last update
Jul 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06745570
Responsible party
Stephanie Manasse (Research Scientist, Nemours Children's Clinic) — Principal investigator
First posted
Dec 20, 2024
Start date
Apr 18, 2024
Primary completion
Jan 15, 2027 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Jul 20, 2026

Study contacts

Stephanie Manasse, Ph.D
Contact
aspirelab@nemours.org
3022988390
Stephanie Manasse, Ph.D.
principal investigator · Nemours Children's Clinic

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion